ACTB and glioblastoma: Arginine deprivation therapy (ADT) exerts a profound impact on the adhesion, invasive-ness, and cytoskeletal dynamics of glioblastoma (GBM) cells, predominantly through the modulation of β-actin arginylation (Pavlyk et al., 2015).